fluticasone furoate and vilanterol

Action and Spectrum

Drug Interaction

Adverse Reaction

Adverse drug reactions:   

 Frequency Defined  

1-10%  

Nasopharyngitis  

Sinusitis  

Headache  

<1%  

Oral Candidiasis  

Post-Marketing Reports  

Angina pectoris  

cardiac arrhythmias   

QT prolongation  

elevated blood pressure  

Black Box Warning

Contraindication / Caution

Pregnancy / Lactation

Pregnancy warnings:     

Pregnancy Category: N/A 

Lactation: unknown if distributed into breast milk, avoid 

Pregnancy Categories:       

Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.       

Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women       

Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women       

Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.       

Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.       

Category N: There is no data available for the drug under this category 

Pharmacology

Adminstartion

Patient Information Leaflet

Patient Information Leaflet    

Generic Name: Fluticasone furoate and vilanterol 

Why do we use Fluticasone furoate and vilanterol? 

Fluticasone furoate and vilanterol is an Beta2 Agonists, Corticosteroids, and it is used to treat COPD and severe Asthma.